Liquid-phase Chemical Synthesis Method for Oligonucleotide
Advantages of Liquid-phase Chemical Synthesis Method
The liquid-phase technique provides an alternative to the extensively employed solid-phase oligonucleotide synthesis method. In this strategy, a soluble polymeric carrier integrated into the reaction medium acts as the scaffold for elongating the chain. Afterward, the polymer is separated from unused reagents and soluble by-products using filtration or crystallization techniques. This approach eliminates any inconsistency resulting from support insolubility, thus enhancing the potential for process upscaling. This is particularly pertinent now as synthetic oligonucleotides are transitioning from research settings to practical biomedical applications. Consequently, the scientific community is actively exploring the development and evaluation of a more user-friendly liquid-phase chemical synthesis method for oligonucleotides. An innovative strategy known as high-performance liquid phase (HELP), utilizing soluble polyethylene glycol (PEG) as a polymeric support and employing phosphotriester chemistry for the coupling reaction, has demonstrated promising outcomes.
Key Technologies
Our liquid-phase synthesis platform is built upon a modified phosphoramidite chemistry, the most widely used technique for DNA and RNA synthesis. Unlike solid-phase synthesis, which uses an insoluble support, our liquid-phase oligonucleotide synthesis method utilizes a soluble polymeric support that remains dissolved in the reaction solvent. This homogeneous reaction environment provides several key advantages, including better reagent accessibility and more predictable, linear reaction kinetics. This approach allows for a reduction in the large excesses of expensive amidite monomers typically required in solid-phase methods to drive reactions to completion. Our innovative "one-pot" liquid-phase oligonucleotide technique for DNA synthesis allows for sequential coupling, oxidation, and deprotection in a single reaction vessel, followed by a single precipitation step, drastically streamlining the process and reducing overall solvent consumption.
Liquid-Phase Precision, Nucleotide by Nucleotide
CD BioGlyco commits to providing global clients with industry-leading Custom Carbohydrate Synthesis services, such as Custom Sugar-nucleotides Synthesis services. The HELP-based Synthesis of Oligonucleotides we provide mainly includes 3 key steps: functionalization of PEG, oligonucleotide assembly, deprotection & purification.
- PEG Functionalization
The initial nucleoside is attached through PEG, which is linked to a symmetrical anhydride derivative of four 5'-O-dimethoxytrityl (DMT)-2'-deoxynucleoside-3'-O-succinates. The PEG-nucleosides are then subjected to analysis using 1H-NMR spectroscopy. To confirm the complete removal of reagents, TLC is initially employed, followed by product characterization. Any residual unreacted PEG molecules are treated with acetic anhydride. - Oligonucleotide assembly
The process of oligonucleotide assembly is executed through detritylation, condensation, capping, and oxidation steps, adhering to established procedures. - Deprotection & purification
Upon the synthesis's completion, the oligomers are separated from the polymer using standard deprotection techniques. Most of the product is detached from PEG through oximation, succeeded by comprehensive hydrolysis using concentrated ammonia. Partially deprotected oligonucleotides are subjected to analysis via HPLC. Finally, after full deprotection with acetic acid, the product undergoes purification through ion exchange chromatography.
Workflow
Fig.1 Process of HELP for oligonucleotide synthesis. (CD BioGlyco)
Publication Data
DOI.: 10.1021/acs.oprd.5c00117
Journal: Organic Process Research & Development
Published: 2025
IF: 3.5
Results: Employing solvent-defying ceramic membranology, this scalable one-pot approach revolutionizes liquid-phase oligonucleotide fabrication. Authors covalently tethered elongating phosphorothioate 2'-O-methyl oligonucleotides to branched-polyethylene-glycol matrices, artfully integrating iterative phosphoramidite coupling, sulfurization, and acid-mediated detritylation. Membrane-filtration purification occurs concomitantly, streamlining processes traditionally necessitating laborious intermediate isolations, a synthesis strategy embodying stoichiometric precision and macromolecular engineering ingenuity. Using ultrafiltration and nanofiltration ceramic membranes, they achieved high stepwise filtration yields and crude purity with only 1.5 equivalents of phosphoramidites. The membranes selectively retained PEG-oligonucleotide conjugates while removing low-MW impurities. This approach reduced unit operations, solvent consumption, and process mass intensity compared to solid-phase synthesis, demonstrating feasibility for gram-scale therapeutic oligonucleotide production with efficient intermediate purification.
Applications of Liquid-phase Chemical Synthesis Method
- Biomedical research: The liquid-phase synthesis method is extensively used to produce custom oligonucleotides for various research purposes, such as investigating gene expression, studying genetic variations, and exploring nucleic acid-protein interactions.
- Diagnostic assays: Oligonucleotides synthesized using the liquid-phase method are crucial components of diagnostic assays, including polymerase chain reactions (PCR), reverse transcription PCR (RT-PCR), and nucleic acid hybridization techniques.
- Next-generation sequencing (NGS): Oligonucleotides produced through the liquid-phase approach serve as primers and adapters in NGS technologies. They facilitate the high-throughput sequencing of DNA and RNA, enabling comprehensive genomic and transcriptomic analyses.
Advantages
- Liquid-phase oligonucleotide synthesis employs a uniform reaction mixture, enabling potentially boundless scalability.
- Oligonucleotides are synthesized using the liquid-phase technique and hold the potential for advancing extensive drug development efforts.
- The liquid-phase approach to oligonucleotide synthesis is expected to contribute to the progression of large-scale fabrication of DNA materials.
Frequently Asked Questions
Associated Services
Liquid-phase chemical synthesis for oligonucleotides, leveraging soluble polymer supports (e.g., PEG) and homogeneous reaction conditions, enables scalable, cost-effective production of DNA/RNA sequences with reduced reagent consumption and streamlined purification via precipitation or membrane filtration. Forwarding glycotherapeutic vectors and nucleic-acid-conjugate integrations, this platform necessitates co-delivered-associated enzymatic services: concerted enzymatic catalysis fabricates nucleotide sugar donors satisfying exacting purity specifications.
At CD BioGlyco, we have established the high-quality Glyco™ Synthesis Platform that is dedicated to glycobiology research. Our commitment to excellence is evident in every aspect of the Chemical-based Oligonucleotide Synthesis Service. Our team is dedicated to maintaining the highest standards and ensuring client satisfaction, particularly in the realm of liquid-phase chemical synthesis methods for oligonucleotides. If you are interested in our services, please do not hesitate to contact us for more details.
Reference
- Kelly, R.; et al. Scalable membrane enabled one-pot liquid-phase oligonucleotide synthesis. Organic Process Research & Development. 2025, 29(6): 1577-1592. (Open Access)
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform






